Green Thumb Industries Reports Modest Revenue Growth Amid Pricing Pressures — Green Thumb Industries Inc.

Event summary

Revenue increased by 4.6% year-over-year to $306.7 million in Q2 2026.
Normalized EBITDA rose to $84.3 million, representing 27.5% of revenue.
Repurchased approximately 7.9 million Subordinate Voting Shares for $48.3 million during the quarter.
Virginia authorized adult-use sales beginning July 1, 2027, where Green Thumb holds a vertically integrated medical cannabis license.
Named to TIME America’s Best Companies 2026 list.

The big picture

Green Thumb Industries continues to navigate persistent pricing pressures in key markets, leveraging its scale and brand portfolio to drive modest revenue growth. The company's strategic focus on wholesale business and retail expansion positions it favorably as regulatory shifts favor licensed cannabis operators. With a solid balance sheet and disciplined capital allocation, Green Thumb aims to capitalize on emerging opportunities in Virginia and Texas while maintaining operational efficiency.

What we're watching

Market Expansion: The pace at which Green Thumb can capitalize on the upcoming adult-use sales in Virginia and Texas, which together account for roughly 12% of the U.S. population.
Regulatory Shifts: Whether the transition from hemp products to licensed cannabis channels will favor operators with existing scale and shelf space, as suggested by management.
Operational Efficiency: How Green Thumb's increased investment in its team will impact near-term EBITDA margins and long-term operational performance.